Nurse Practitioner · Omaha, NE
NPI
1316494164
Since 2016
Specialty
Nurse Practitioner
Code 363L00000X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
4242 Farnam St, Ste 650
Omaha, NE, 68131
Phone (402) 559-8600
Groups this clinician bills Medicare through
Medicare paid, 2024
$7,209
160 services
Medicare patients, 2024
84
Average age 60
Drug cost, 2024
$683K
1,687 prescriptions
Company payments, 2025
$337
From 3 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Autumn R Nye was code 62370 (musculoskeletal), 36 times for 15 patients. In total Autumn R Nye billed 160 services in 9 codes, and Medicare paid $7,209.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2017-03-15.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 62370 Musculoskeletal | Facility | 36 | 15 | $22.81 | $821 |
| 64615 Musculoskeletal | Facility | 28 | 13 | $62.86 | $1,760 |
| 99214 Office E&M - Established | Facility | 26 | 22 | $47.97 | $1,247 |
| 99214 Office E&M - Established | Office | 21 | 14 | $58.34 | $1,225 |
| 99213 Office E&M - Established | Facility | 13 | 11 | $28.27 | $368 |
By year: 2022 $6,072 for 137 services; 2023 $5,836 for 144 services; 2024 $7,209 for 160 services.
Medicare prescription drug claims, 2024
In 2024, the drug Autumn R Nye prescribed most often to Medicare patients was Emgality Pen (Galcanezumab-Gnlm), with 335 prescriptions and refills. In total Autumn R Nye wrote 1,687 Medicare prescriptions that cost $683K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Emgality Pen Galcanezumab-Gnlm | 335 | 340 | 38 | $226K |
| Topiramate Generic | 184 | 245 | 30 | $1,804 |
| Aimovig Autoinjector Erenumab-Aooe | 106 | 106 | 14 | $75K |
| Ubrelvy Ubrogepant | 103 | 107 | 26 | $124K |
| Sumatriptan Succinate Generic | 99 | 122 | 22 | $2,568 |
| Amitriptyline Hcl Generic | 95 | 117 | 15 | $1,308 |
| Gabapentin Generic | 86 | 103 | 18 | $1,284 |
| Nurtec Odt Rimegepant Sulfate | 83 | 90 | 16 | $131K |
| Naratriptan Hcl Generic | 66 | 72 | 20 | $2,066 |
| Ajovy Autoinjector Fremanezumab-Vfrm | 57 | 59 | Under 11 | $39K |
| Rizatriptan Rizatriptan Benzoate | 40 | 43 | 12 | $1,157 |
| Ondansetron Odt Ondansetron | 38 | 38 | Under 11 | $495 |
| Emgality Syringe Galcanezumab-Gnlm | 32 | 32 | Under 11 | $23K |
| Pregabalin Generic | 28 | 40 | Under 11 | $553 |
| Qulipta Atogepant | 28 | 28 | Under 11 | $33K |
Brand drugs: 774 claims; generic drugs: 913 claims; opioid claims: 12.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Autumn R Nye $337 ($337 in general payments such as food, travel and fees) from 3 companies. The largest payer was Lundbeck LLC with $160.
| Company | Payments | Amount |
|---|---|---|
| Lundbeck LLC | 2 | $160 |
| Piramal Critical Care | 1 | $120 |
| Medtronic, Inc. MDT | 2 | $57.52 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.